117 related articles for article (PubMed ID: 38447779)
21. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y
Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258
[TBL] [Abstract][Full Text] [Related]
23. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel.
Long J; Hu W; Ren T; Wang X; Lu C; Pan X; Wu C; Peng T
Int J Pharm; 2024 Jan; 650():123718. PubMed ID: 38104849
[TBL] [Abstract][Full Text] [Related]
24. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
Milane LS; Dolare S; Ren G; Amiji M
J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
[TBL] [Abstract][Full Text] [Related]
25. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
26. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.
Ma Z; Li N; Zhang B; Hui Y; Zhang Y; Lu P; Pi J; Liu Z
J Nanobiotechnology; 2020 Sep; 18(1):123. PubMed ID: 32887626
[TBL] [Abstract][Full Text] [Related]
27. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity.
Cheng Y; Ji Y
J Control Release; 2020 Feb; 318():38-49. PubMed ID: 31830542
[TBL] [Abstract][Full Text] [Related]
29. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
[TBL] [Abstract][Full Text] [Related]
30. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
[TBL] [Abstract][Full Text] [Related]
31. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
32. VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.
Tang B; Qian Y; Gou Y; Cheng G; Fang G
Molecules; 2018 Oct; 23(11):. PubMed ID: 30366367
[TBL] [Abstract][Full Text] [Related]
33. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
Hu L; Li M; Zhang Z; Shen Y; Guo S
Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
[TBL] [Abstract][Full Text] [Related]
34. Theranostic micelles combined with multiple strategies to effectively overcome multidrug resistance.
Zhao D; Chen Q; Song H; Luo S; Ge P; Wang Y; Ma J; Li Z; Gao X; Zhao X; Subinuer X; Yang H; Jiang X; Chen Y; Zhu X
Nanomedicine (Lond); 2018 Jul; 13(13):1517-1533. PubMed ID: 30028224
[TBL] [Abstract][Full Text] [Related]
35. pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer.
Wang H; Shi W; Zeng D; Huang Q; Xie J; Wen H; Li J; Yu X; Qin L; Zhou Y
J Nanobiotechnology; 2021 May; 19(1):152. PubMed ID: 34022909
[TBL] [Abstract][Full Text] [Related]
36. Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release.
Ma P; Chen J; Bi X; Li Z; Gao X; Li H; Zhu H; Huang Y; Qi J; Zhang Y
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12351-12363. PubMed ID: 29569435
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria Targeted Nanoparticles Potentiate Tumor Chemo-Phototherapy by Toxic Oxidative Stress Mediated Oxeiptosis.
Lu Z; Li J; Chen B; Feng J; Hu Q; Jin Y; Fu Z
Macromol Biosci; 2023 Nov; 23(11):e2300151. PubMed ID: 37295777
[TBL] [Abstract][Full Text] [Related]
38. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
[TBL] [Abstract][Full Text] [Related]
40. Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG
Wang P; Wang Y; Xia X; Huang W; Yan D
Biomater Sci; 2023 Jun; 11(12):4335-4345. PubMed ID: 37133364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
